The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 19, 2021

Filed:

Dec. 20, 2018
Applicant:

Allergan, Inc., Irvine, CA (US);

Inventors:

Birgitte P S Jacky, Orange, CA (US);

Amy Brideau-Andersen, San Clemente, CA (US);

Hui You, Irvine, CA (US);

Shiazah Z. Malik, Irvine, CA (US);

Donald E. Frail, Laguna Hills, CA (US);

Mitchell F. Brin, Newport Beach, CA (US);

Assignee:

Alleergan, Inc., Irvine, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61P 17/10 (2006.01); A61P 17/06 (2006.01); C12N 9/52 (2006.01); A61K 38/48 (2006.01); A61K 9/00 (2006.01); A61P 35/00 (2006.01); A61P 13/10 (2006.01); A61P 13/08 (2006.01); A61P 1/18 (2006.01); A61P 17/02 (2006.01); A61P 37/00 (2006.01); A61P 17/08 (2006.01); A61P 29/00 (2006.01); A61Q 19/00 (2006.01); A61Q 19/08 (2006.01); C07K 14/315 (2006.01); C07K 14/33 (2006.01);
U.S. Cl.
CPC ...
C12N 9/52 (2013.01); A61K 9/0014 (2013.01); A61K 9/0019 (2013.01); A61K 38/4893 (2013.01); A61P 1/18 (2018.01); A61P 13/08 (2018.01); A61P 13/10 (2018.01); A61P 17/02 (2018.01); A61P 17/06 (2018.01); A61P 17/08 (2018.01); A61P 17/10 (2018.01); A61P 29/00 (2018.01); A61P 35/00 (2018.01); A61P 37/00 (2018.01); A61Q 19/007 (2013.01); A61Q 19/008 (2013.01); A61Q 19/08 (2013.01); C07K 14/315 (2013.01); C07K 14/33 (2013.01); C12Y 304/24069 (2013.01); C07K 2319/00 (2013.01);
Abstract

A polypeptide having an amino acid sequence corresponding to a binding domain of a botulinum toxin is described. The polypeptide modulates expression of genes involved in, for example, collagen production and extra cellular matrix organization, and finds use, therefore in modulating skin quality attributes such as elasticity, firmness etc. Moreover, the polypeptide inhibits lipogenesis in specialized cells and finds use, therefore, in reducing skin oiliness, which is frequently observed in skin tissue afflicted with large pores and acne. Nucleic acids encoding the polypeptide, as well as vectors, host cells, and systems comprising the nucleic acids, are further described.


Find Patent Forward Citations

Loading…